The Limited Times

Now you can see non-English news...

Covid-19: vaccination centers soon to be relaunched

2021-11-18T16:47:09.676Z


UPDATE ON THE SITUATION - New measures, new reports and highlights: Le Figaro takes stock of the latest developments in the pandemic.


Vaccination centers will make their comeback in France, no injection for children under 12 before February, Bruno Le Maire "

not in favor

" of the confinement of unvaccinated people ...

Le Figaro

takes stock this Thursday November 18 on the latest information related to the Covid-19 pandemic.

Read alsoCovid-19: is it normal that there are now more vaccinated than unvaccinated in the hospital?

Vaccination centers relaunched in France

Vaccination centers, which had closed at the end of the summer after six months of a mass vaccination campaign, will "

resume activity

" to help with the booster dose, government spokesman Gabriel said Thursday. Attal. "

With the increase in injections linked to the vaccination booster, today for those over 65 and tomorrow for those over 50, this may lead to vaccination centers which had closed - or which had reduced the wing - to resume an activity

", indicated Gabriel Attal on LCI, questioned on a possible reopening of"

vaccinodromes

"in the coming weeks.

The vaccination centers "

have shown all their effectiveness, they are identified

", and "

the French know them, they know where to go

", he pleaded.

People over 65 and those with comorbidities can for several weeks make a booster, otherwise they will see their health pass deactivated, "

six months and five weeks

" after the previous injection, from December 15.

For 50-64 year olds, the recall campaign will be open from the beginning of December.

Read alsoCovid-19: who are really the more than six million unvaccinated French people?

No vaccination of children under 12 before February, according to Gabriel Attal

Invited on LCI this Thursday, Gabriel Attal, government spokesperson, said that the decision to open vaccination to children aged 5 to 12 will not be taken before February 2022. “

We make decisions as soon as we has scientific recommendations that tell us 'we recommend it to you

', ”he said.

On the vaccination of children, the European health agency should give us its opinion by the end of the year.

Then the French authority must give us an opinion.

We do not expect it before the start of 2022. This subject is far from trivial.

It is normal for the health authorities to take the time,

”the government spokesperson explained.

"SEE ALSO - Covid-19: no vaccination for children under 12 before February, according to Gabriel Attal

Bruno Le Maire is "

not in favor

" of the confinement of unvaccinated people

The Minister of the Economy said on RMC on Thursday that he was “

not in favor

” of a confinement that would only affect unvaccinated people, calling this measure “

discriminatory

”. "

I am above all in favor of avoiding these measures, of avoiding new confinement, and of everyone making the necessary effort to be vaccinated, to protect themselves

", commented Bruno Le Maire. . Saying "

share the concern

" of professionals in the face of a fifth wave that could parasitize the holiday season, the boss of Bercy estimated that France could not "

afford

" a new confinement. "

It would be too hard for the French, the restaurateurs, the traders, for each of us, for our children, for French society as a whole

”, judged the minister.

Read alsoCovid-19: in France, protective vaccination coverage but not infallible

Teleworking: no tougher rules in sight at this stage

The government does not plan at this stage to strengthen the rules on teleworking in the face of the fifth wave of the Covid-19 epidemic, the Ministry of Labor said Thursday. "

We do not plan today to strengthen the rules on teleworking

", said the ministry, arguing that "

the situation is not the same as last spring

", with "

today 90% of adults who are vaccinated

”.

The ministry also highlights the "

strict health protocol that applies in companies, with the wearing of the mask compulsory in all closed and shared work spaces as well as the respect of barrier gestures

".

In an interview with Opinion.fr, the Minister of Labor, Elisabeth Borne, spoke on Thursday of a "

demanding

"

protocol

, deploring "

a certain relaxation in recent months, particularly on the wearing of a mask

".

"

Everyone must get back on track

," she insisted, adding that labor inspection controls would be strengthened on compliance with the protocol.

Read also Teleworking: the government pushes back the time for decisions

Senate report suggests '

boosting support

' overseas

The fourth wave of Covid-19 caused an "

epidemic tsunami

" in the overseas territories, according to a joint Senate information mission which proposes to territorialize the responses and amplify support for these territories "

still too vulnerable to the risks of epidemic resumption

”.

"

Overseas represent 4% of the French population, but more than 30% of deaths linked to Covid and which occurred in hospitals from the beginning of July to the end of October,

" this mission recalls in a report on Thursday.

Intended to assess the effects of measures taken or envisaged in terms of containment or activity restrictions, it is chaired by Senator PS Bernard Jomier.

In overseas territories, the delta variant affected “

populations less affected by previous waves, and therefore less immune, much less vaccinated than in metropolitan France (between 20 and 35 percentage points less depending on the territories), and more exposed due to more frequent comorbidities: overweight and obesity, diabetes, hypertension,

”the report explains.

»SEE ALSO - Covid-19: in Guadeloupe, the general strike against the vaccine obligation continues under high tension

Germany: hospitals under high voltage

With the new wave of Covid-19, Germany is wondering how long its health system will last, while its hospitals have "

4,000 intensive care beds less than a year ago due to nursing staff exhausted who quit his job or reduced his working time

, ”according to Gernot Marx, president of the German Association for Intensive Medicine (DIVI).

Read also In Germany, an anti-Covid strategy deemed "chaotic"

AstraZeneca announces successful trials for Covid-19 drug

British pharmaceutical giant AstraZeneca in turn announced successful advanced clinical trials for an antibody-based drug against Covid-19 in high-risk patients. The Anglo-Swedish laboratory is thus following in the footsteps of the Americans Merck and Pfizer, who had respectively proclaimed in October and early November that they had managed to develop drugs to prevent severe forms of the disease and to take at the first symptoms. .

The six-month follow-up of a first trial consisting of injecting a 300 mg dose of the drug AZD7442 “

showed an 83% reduction in the risk

” of developing a symptomatic form of Covid, Astra Zeneca said in a statement Thursday. "

No serious form of the disease or any death

" linked to Covid were counted during the test, said the laboratory. At the start of the study, more than 75% of participants had comorbidities that put them at high risk of severe disease if infected. A second test has meanwhile "

shown an 88% reduction in the risk of severe Covid-19 or death when treated within three days of the onset of symptoms

."

Read also AstraZeneca wants to make profitable its anti-Covid vaccine

US orders 10 million treatments of its anti-Covid pill from Pfizer

The Pfizer laboratory announced in a statement Thursday that the US government had ordered 10 million treatments of its anti-Covid pill for $ 5.29 billion, subject to the drug receiving the green light from health authorities.

The group, which already markets a vaccine against the virus in collaboration with BioNTech, filed at the beginning of the week with the American Medicines Agency (FDA) an emergency authorization request for this highly anticipated treatment because it can easily be taken at home in the first few days after the onset of symptoms in case of infection.

This antiviral treatment, which will be marketed under the name Paxlovid, has been shown to be 89% effective against hospitalizations and death in clinical trials, when taken within three days of symptom onset.

These trials were conducted by the company on people at high risk of developing a severe case of Covid-19.

»SEE ALSO - Pfizer signs agreement for global access to its anti-Covid pill

More than 5.1 million deaths worldwide

The new coronavirus pandemic has killed at least 5,122,675 people around the world since the end of 2019, according to a report established by AFP.

More than 254,952,650 cases of infection have been officially diagnosed since the start of the epidemic.

The United States is the most affected country, with 767,435 deaths, ahead of Brazil (611,851), India (464,623) and Mexico (291,573).

The World Health Organization (WHO) estimates, taking into account the excess mortality directly and indirectly linked to Covid-19, that the overall toll of the pandemic could be two to three times higher than that calculated from official figures .

Source: lefigaro

All tech articles on 2021-11-18

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.